CA2139169A1 - Antiherpes peptidomimetic compounds - Google Patents
Antiherpes peptidomimetic compoundsInfo
- Publication number
- CA2139169A1 CA2139169A1 CA002139169A CA2139169A CA2139169A1 CA 2139169 A1 CA2139169 A1 CA 2139169A1 CA 002139169 A CA002139169 A CA 002139169A CA 2139169 A CA2139169 A CA 2139169A CA 2139169 A1 CA2139169 A1 CA 2139169A1
- Authority
- CA
- Canada
- Prior art keywords
- antiherpes
- peptidomimetic compounds
- alkyl
- compounds
- peptidomimetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Storing, Repeated Paying-Out, And Re-Storing Of Elongated Articles (AREA)
Abstract
Disclosed herein are compounds of the formula
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002139169A CA2139169C (en) | 1994-12-28 | 1994-12-28 | Antiherpes peptidomimetic compounds |
CA002230750A CA2230750C (en) | 1994-12-28 | 1994-12-28 | Antiherpes peptidomimetic compounds |
US08/460,957 US5846941A (en) | 1992-03-12 | 1995-06-05 | Isosteric antiherpes peptide derivatives II |
JP8520086A JPH10511362A (en) | 1994-12-28 | 1995-10-31 | Anti-herpes peptidomimetic compound |
MX9704548A MX9704548A (en) | 1994-12-28 | 1995-10-31 | Antiherpes peptidomimetic compounds. |
DE69514388T DE69514388T2 (en) | 1994-12-28 | 1995-10-31 | ANTIHERPETIC PEPTIDOMIMETIC COMPOUNDS |
AU37395/95A AU3739595A (en) | 1994-12-28 | 1995-10-31 | Antiherpes peptidomimetic compounds |
EP95935318A EP0800512B1 (en) | 1994-12-28 | 1995-10-31 | Antiherpes peptidomimetic compounds |
AT95935318T ATE188468T1 (en) | 1994-12-28 | 1995-10-31 | ANTIHERPETIC PEPTIDOMIMMETIC COMPOUNDS |
PCT/CA1995/000626 WO1996020171A1 (en) | 1994-12-28 | 1995-10-31 | Antiherpes peptidomimetic compounds |
TW084112900A TW432035B (en) | 1994-12-28 | 1995-12-04 | Antiherpes peptidomimetic compounds |
IL11655795A IL116557A0 (en) | 1994-12-28 | 1995-12-26 | Antiherpes peptidomimetic compounds their preparation and pharmaceutical compositions containing them |
ZA9510964A ZA9510964B (en) | 1994-12-28 | 1995-12-27 | Antiherpes peptidomimetic compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002139169A CA2139169C (en) | 1994-12-28 | 1994-12-28 | Antiherpes peptidomimetic compounds |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002230750A Division CA2230750C (en) | 1994-12-28 | 1994-12-28 | Antiherpes peptidomimetic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2139169A1 true CA2139169A1 (en) | 1996-06-29 |
CA2139169C CA2139169C (en) | 2001-05-01 |
Family
ID=4154943
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002230750A Expired - Fee Related CA2230750C (en) | 1994-12-28 | 1994-12-28 | Antiherpes peptidomimetic compounds |
CA002139169A Expired - Fee Related CA2139169C (en) | 1992-03-12 | 1994-12-28 | Antiherpes peptidomimetic compounds |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002230750A Expired - Fee Related CA2230750C (en) | 1994-12-28 | 1994-12-28 | Antiherpes peptidomimetic compounds |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0800512B1 (en) |
JP (1) | JPH10511362A (en) |
AT (1) | ATE188468T1 (en) |
AU (1) | AU3739595A (en) |
CA (2) | CA2230750C (en) |
DE (1) | DE69514388T2 (en) |
IL (1) | IL116557A0 (en) |
MX (1) | MX9704548A (en) |
TW (1) | TW432035B (en) |
WO (1) | WO1996020171A1 (en) |
ZA (1) | ZA9510964B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE169931T1 (en) * | 1992-03-12 | 1998-09-15 | Boehringer Ingelheim Ca Ltd | ISOSTERIC PEPTIDE DERIVATIVES AGAINST HERPES |
CA2095408A1 (en) * | 1993-05-03 | 1994-11-04 | James Gus Chafouleas | Method of combating acyclovir-resistant herpes simplex viral infections |
-
1994
- 1994-12-28 CA CA002230750A patent/CA2230750C/en not_active Expired - Fee Related
- 1994-12-28 CA CA002139169A patent/CA2139169C/en not_active Expired - Fee Related
-
1995
- 1995-10-31 AU AU37395/95A patent/AU3739595A/en not_active Abandoned
- 1995-10-31 JP JP8520086A patent/JPH10511362A/en not_active Abandoned
- 1995-10-31 DE DE69514388T patent/DE69514388T2/en not_active Expired - Fee Related
- 1995-10-31 AT AT95935318T patent/ATE188468T1/en not_active IP Right Cessation
- 1995-10-31 EP EP95935318A patent/EP0800512B1/en not_active Expired - Lifetime
- 1995-10-31 MX MX9704548A patent/MX9704548A/en not_active IP Right Cessation
- 1995-10-31 WO PCT/CA1995/000626 patent/WO1996020171A1/en active IP Right Grant
- 1995-12-04 TW TW084112900A patent/TW432035B/en active
- 1995-12-26 IL IL11655795A patent/IL116557A0/en unknown
- 1995-12-27 ZA ZA9510964A patent/ZA9510964B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2230750A1 (en) | 1996-06-29 |
DE69514388D1 (en) | 2000-02-10 |
EP0800512A1 (en) | 1997-10-15 |
MX9704548A (en) | 1998-02-28 |
DE69514388T2 (en) | 2000-07-27 |
TW432035B (en) | 2001-05-01 |
CA2139169C (en) | 2001-05-01 |
JPH10511362A (en) | 1998-11-04 |
WO1996020171A1 (en) | 1996-07-04 |
CA2230750C (en) | 2002-05-21 |
AU3739595A (en) | 1996-07-19 |
EP0800512B1 (en) | 2000-01-05 |
ATE188468T1 (en) | 2000-01-15 |
IL116557A0 (en) | 1996-03-31 |
ZA9510964B (en) | 1996-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2037408A1 (en) | A nonaqueous pharmaceutical macrolide solution | |
CA2225761A1 (en) | Difluoroprostaglandin derivatives and their use | |
CA2113914A1 (en) | Phospholipid derivative and liposome containing it | |
CA2412554A1 (en) | 3-substituted morphines | |
CA2189603A1 (en) | Propiophenone derivative and processes for preparing the same | |
CA2094859A1 (en) | Anticonvulsant fructopyranose cyclic sulfites and sulfates | |
CA2189830A1 (en) | Uses for Corticotropin Releasing Factor Atagonists | |
CA2168016A1 (en) | Benzimidazole Derivatives | |
CA2136999A1 (en) | Peripheral vasodilating agent containing piperidine derivative as active ingredient | |
CA2379270A1 (en) | External preparation for skin diseases containing nitroimidazole | |
EP2044938A3 (en) | Radioprotectors | |
CA2188841A1 (en) | Use of 2-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for the prophylaxis and treatment of the sequelae of acute and chronic reduced cerebral blood supply and neurodegenerative disorders | |
CA2297011A1 (en) | Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy | |
CA2115536A1 (en) | Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives | |
CA2378483A1 (en) | Crystalline 1-methylcarbapenem compounds | |
CA2241092A1 (en) | 1-methylcarbapenem derivatives | |
CA2530543A1 (en) | Illudin analogs as anti-tumor agents | |
AU670121B2 (en) | Antiretroviral acyl compounds | |
CA2011987A1 (en) | Herbicidal 1,3,5-triazin-2-ylaminocarbonylamino-sulfonylbenzoic esters, the preparation and use thereof | |
USD297107S (en) | Combined cushioned doorknob cover and wall protector | |
CA2029704A1 (en) | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders | |
CA2011238A1 (en) | Pharmaceutical treatment | |
CA2139169A1 (en) | Antiherpes peptidomimetic compounds | |
CA2102960A1 (en) | Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds | |
CA2309473A1 (en) | New 4-arylpiperidine derivatives for the treatment of pruritus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |